Comparison |
| Alternate Manufacturer Number |
3906187 | 2017226 | 1904341 | 3243706 | 3513678 |
| Container Type |
Single-Dose Vial | Infusion Bottle | Flexible Bag | Prefilled Syringe | Prefilled Syringe |
| Country of Origin |
Unknown | India | Unknown | Unknown | Unknown |
| Generic Drug Code |
19476 | 25026 | 34228 | 26368 | 26368 |
| Generic Drug Name |
Zoledronic Acid | Zoledronic Acid / Mannitol-Water | Zoledronic Acid / Mannitol-Water | Ibandronate Sodium | Ibandronate Sodium |
| NDC Number |
16714081501 | 55111068852 | 25021083082 | 67457052433 | 60505609700 |
| Strength |
4 mg / 5 mL Concentrate | 5 mg / 100 mL | 5 mg / 100 mL | 1 mg / mL | 1 mg / mL |
| UNSPSC Code |
51182415 | 51182415 | 51182415 | 51182423 | 51182423 |
| Volume |
5 mL | 100 mL | 100 mL | 3 mL | 3 mL |
| Application |
Bone Resorption Inhibitor | Bone Resorption Inhibitor | Bone Resorption Inhibitor | Bone Resorption Inhibitor | Bone Resorption Inhibitor |
| Dosage Form |
Injection | Injection | Injection | Injection | Injection |
| Product Dating |
McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days | McKesson Acceptable Dating: we will ship >= 90 days |
| Type |
Intravenous | Intravenous | Intravenous | Intravenous | Intravenous |
| Features and Benefits |
|
- Ready-to-use formulation
- Zoledronic acid injection is a bisphosphonate indicated for the treatment of: Hypercalcemia of malignancy, multiple myeloma and bone metastases from solid tumors
- The zoledronic acid injection infusion time must not be less than 15 minutes given over a constant infusion rate
- Zoledronic acid injection must not be mixed with calcium or other divalent cation-containing infusion solutions, such as Lactated Ringer’s solution, and should be administered as a single intravenous solution in a line separate from all other drugs
- Infusion bottle with built-in plastic hanger
- One bottle with 100 mL solution contains 5.330 mg of zoledronic acid monohydrate, equivalent to 5 mg zoledronic acid on an anhydrous basis
- Inactive Ingredients: 4950 mg of mannitol, USP; and 30 mg of sodium citrate, USP
|
|
- Ibandronate sodium injection is supplied as a kit containing a 3 mg/3 mL of ibandronic acid in a single-dose, clear glass, 5 mL (5 cc) prefilled syringe, a 25-gauge, 3/4 inch needle with wings, needle-stick protection device, and a 9 cm plastic tubing for attachment
|
|
